bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Sees Large Growth in Short Interest

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 1,300 shares, a growth of 160.0% from the May 31st total of 500 shares. Based on an average trading volume of 1,700 shares, the short-interest ratio is presently 0.8 days.

bioAffinity Technologies Price Performance

Shares of BIAFW stock remained flat at $0.30 on Friday. The business’s 50 day simple moving average is $0.39 and its two-hundred day simple moving average is $0.31. bioAffinity Technologies has a 1 year low of $0.05 and a 1 year high of $0.90.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.